10/19/2026
Altrova Health has announced its first U.S. sale of 2,000 O-Sprayβ’ units. O-Spray is a needle-free sublingual oral spray dosage format designed as an alternative to self-injection, pill and syringe-based administration.
Join our investor Q&A session on Tuesday, October 20 at 10:00 a.m. ET. Details and the full release are here: https://www.newsfilecorp.com/release/319738